Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic ...

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements in measures of both systemic and cutaneous disease activity ...

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...

Below, Kiana Cornejo, 24, shares her story about being pregnant with lupus and the challenges she has faced both during and ...

Researchers have found in a recent meta-analysis that belimumab is more effective than placebo in treating systemic lupus ...

Autoimmune thyroid disorders are common in lupus patients, but do not worsen disease outcomes, a new study finds. APS ...

Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know ...